恶性卵巢甲状腺肿：通过甲状腺球蛋白水平监测复发及对治疗的反应。
Malignant struma ovarii: recurrence and response to treatment monitored by thyroglobulin levels.
作者信息
Rose P G, Arafah B, Abdul-Karim F W
机构信息
Department of Reproductive Biology, Department of Medicine, Institute of Pathology, University Hospitals of Cleveland, Case Western Reserve University, 11100 Euclid Avenue, Cleveland, Ohio, 44106, USA.
出版信息
Gynecol Oncol. 1998 Sep;70(3):425-7. doi: 10.1006/gyno.1998.5056.
A patient with malignant struma ovarii who had elevated thyroglobulin levels at the time of her original surgery was diagnosed with recurrence on the basis of progressive thyroglobulin level elevation while on thyroid suppressive therapy. Subsequent treatment with therapeutic doses of iodine-137 resulted in normalization of the elevated thyroglobulin level. The patient remains disease free on thyroid replacement.
一名原发性手术时甲状腺球蛋白水平升高的恶性卵巢甲状腺肿患者，在接受甲状腺抑制治疗期间，基于甲状腺球蛋白水平持续升高被诊断为复发。随后给予治疗剂量的碘 - 137治疗，使升高的甲状腺球蛋白水平恢复正常。该患者在接受甲状腺替代治疗后仍无疾病复发。
Zotero 插件